CORCEPT THERAPEUTICS ($CORT) posted quarterly earnings results on Monday, May 5th. The company reported earnings of $0.17 per share, beating estimates of $0.15 by $0.02. The company also reported revenue of $157,210,000, missing estimates of $181,494,210 by $-24,284,210.
You can see Quiver Quantitative's $CORT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CORCEPT THERAPEUTICS Insider Trading Activity
CORCEPT THERAPEUTICS insiders have traded $CORT stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $CORT stock by insiders over the last 6 months:
- JOSEPH DOUGLAS LYON (See Remarks) has made 0 purchases and 9 sales selling 217,061 shares for an estimated $21,137,941.
- SEAN MADUCK (See Remarks) has made 0 purchases and 8 sales selling 160,590 shares for an estimated $13,681,416.
- JOSEPH K BELANOFF (Chief Executive Officer) has made 0 purchases and 4 sales selling 40,350 shares for an estimated $3,663,192.
- WILLIAM GUYER (Chief Development Officer) has made 0 purchases and 3 sales selling 24,072 shares for an estimated $1,425,243.
- DANIEL N JR SWISHER has made 0 purchases and 6 sales selling 13,200 shares for an estimated $795,916.
- GARY CHARLES ROBB (Chief Business Officer) has made 0 purchases and 2 sales selling 13,609 shares for an estimated $702,177.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CORCEPT THERAPEUTICS Hedge Fund Activity
We have seen 204 institutional investors add shares of CORCEPT THERAPEUTICS stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NOVO HOLDINGS A/S removed 2,411,362 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $121,508,531
- BLACKROCK, INC. removed 988,917 shares (-6.3%) from their portfolio in Q1 2025, for an estimated $112,954,099
- DIMENSIONAL FUND ADVISORS LP removed 453,931 shares (-17.9%) from their portfolio in Q4 2024, for an estimated $22,873,583
- QUBE RESEARCH & TECHNOLOGIES LTD added 353,730 shares (+604.4%) to their portfolio in Q4 2024, for an estimated $17,824,454
- BOSTON TRUST WALDEN CORP removed 314,261 shares (-35.0%) from their portfolio in Q1 2025, for an estimated $35,894,891
- GEODE CAPITAL MANAGEMENT, LLC removed 310,583 shares (-13.1%) from their portfolio in Q4 2024, for an estimated $15,650,277
- RENAISSANCE TECHNOLOGIES LLC removed 310,400 shares (-4.8%) from their portfolio in Q4 2024, for an estimated $15,641,056
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
